DBV Technologies to Participate in SVB Leerink Global Partners Healthcare Conference
February 19 2021 - 1:30AM
DBV Technologies to Participate in SVB Leerink Global Partners
Healthcare Conference
Montrouge, France, February 19, 2021
DBV Technologies to Participate in SVB
Leerink Global Partners Healthcare Conference
DBV Technologies (Euronext: DBV – ISIN:
FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage
biopharmaceutical company, today announced that Daniel Tassé, Chief
Executive Officer, will participate in a fireside chat at the
virtual SVB Leerink Global Partners Healthcare Conference on
Wednesday, February 24th at 8am ET.
A live webcast of the fireside chat at the SVB
Leerink Global Partners Healthcare Conference will be available on
the Investors & Media section of the Company’s website:
https://www.dbv-technologies.com/investor-relations/. A replay of
the presentation will also be available on DBV’s website after the
event.
About DBV TechnologiesDBV
Technologies is developing Viaskin™, an investigational proprietary
technology platform with broad potential applications in
immunotherapy. Viaskin is based on epicutaneous immunotherapy, or
EPIT™, DBV’s method of delivering biologically active compounds to
the immune system through intact skin. With this new class of
non-invasive product candidates, the Company is dedicated to safely
transforming the care of food allergic patients. DBV’s food
allergies programs include ongoing clinical trials of Viaskin
Peanut. DBV Technologies has global headquarters in Montrouge,
France and offices in Bagneux, France, and North American
operations in Summit, NJ and New York, NY. The Company’s ordinary
shares are traded on segment B of Euronext Paris (Ticker: DBV, ISIN
code: FR0010417345), and the Company’s ADSs (each representing
one-half of one ordinary share) are traded on the Nasdaq Global
Select Market (Ticker: DBVT).
Investor Contact Anne PollakDBV
Technologies+1 857-529-2363anne.pollak@dbv-technologies.com
Media ContactAngela MarcucciDBV
Technologies+1 646-842-2393angela.marcucci@dbv-technologies.com
DBV Technologies (EU:DBV)
Historical Stock Chart
From Aug 2024 to Sep 2024
DBV Technologies (EU:DBV)
Historical Stock Chart
From Sep 2023 to Sep 2024